Rejuvenation (image) InSilico Medicine, Inc. Share Print E-Mail Caption Insilico Medicine, Inc., a company applying latest advances in deep learning to biomarker development, drug discovery and aging research, launched Aging.AI 2.0. Comparing Aging.AI 1.0 using 41 blood biochemistry biomarkers, Aging.AI 2.0 uses just 33 parameters from the blood test and has slightly higher mean absolute error. Credit Insilico Medicine Usage Restrictions None Share Print E-Mail Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.